The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-Ethyl-6,11-dihydro-5H-indolizino [8,7-b]indole-1,2-diyl)dimethanol ID: ALA4065472
PubChem CID: 137633156
Max Phase: Preclinical
Molecular Formula: C18H20N2O2
Molecular Weight: 296.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1c(CO)c(CO)c2n1CCc1c-2[nH]c2ccccc12
Standard InChI: InChI=1S/C18H20N2O2/c1-2-16-13(9-21)14(10-22)18-17-12(7-8-20(16)18)11-5-3-4-6-15(11)19-17/h3-6,19,21-22H,2,7-10H2,1H3
Standard InChI Key: NYOWPPRIKMWYLE-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
10.6399 -10.5565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1173 -9.8923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6302 -9.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8557 -9.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1465 -9.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4417 -9.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4461 -10.3206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1553 -10.7218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8601 -10.3099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5389 -10.3454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2437 -9.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0687 -9.1329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2575 -9.0532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7704 -8.3950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9609 -8.4834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9309 -9.7998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6143 -8.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4039 -8.7256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9944 -10.2560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6527 -9.7731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4581 -11.1586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1219 -11.6352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 1 0
4 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
10 16 2 0
13 16 1 0
2 16 1 0
3 15 1 0
17 18 1 0
12 17 1 0
19 20 1 0
11 19 1 0
10 21 1 0
21 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 296.37Molecular Weight (Monoisotopic): 296.1525AlogP: 2.74#Rotatable Bonds: 3Polar Surface Area: 61.18Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.09CX LogD: 2.09Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.70Np Likeness Score: 0.14
References 1. Chang SM, Christian W, Wu MH, Chen TL, Lin YW, Suen CS, Pidugu HB, Detroja D, Shah A, Hwang MJ, Su TL, Lee TC.. (2017) Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities., 127 [PMID:28064078 ] [10.1016/j.ejmech.2016.12.046 ]